iShares Health Innovation Active ETF(BMED · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $25.79 – $34.86
- YTD
- +12.13%
- IV Rank (30D)
- 33.44
- Straddle Price
- $2.33
iShares Health Innovation Active ETF (BMED) ETF
- Exchange
- ARCX
- Inception
- 2020-09-29
- Has Options
- Yes
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2026-06-15 | 2026-06-18 | $0.0812 | CD |
| 2023-12-20 | 2023-12-27 | $0.0072 | CD |
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| GILD | GILEAD SCIENCES | 5.08% | Equity (US) | US |
| MRK | MERCK & CO INC | 5.05% | Equity (US) | US |
| ABBV | ABBVIE | 4.59% | Equity (US) | US |
| JNJ | JOHNSON & JOHNSON | 4.39% | Equity (US) | US |
| CRL | CHARLES RIVER LABORATORIES INTERNA | 4.22% | Equity (US) | US |
| TMO | THERMO FISHER SCIENTIFIC INC | 4.05% | Equity (US) | US |
| MRNA | MODERNA | 4.02% | Equity (US) | US |
| EW | EDWARDS LIFESCIENCES | 3.83% | Equity (US) | US |
| IQV | IQVIA HOLDINGS | 3.79% | Equity (US) | US |
| VRTX | VERTEX PHARMACEUTICALS | 3.58% | Equity (US) | US |
| DHR | DANAHER | 3.53% | Equity (US) | US |
| BIIB | BIOGEN | 3.50% | Equity (US) | US |
| WAT | WATERS CORP | 3.45% | Equity (US) | US |
| MTD | METTLER TOLEDO | 2.99% | Equity (US) | US |
| AMGN | AMGEN INC | 2.59% | Equity (US) | US |
| ROP | ROCHE PS PAR AG | 2.58% | Equity (Foreign) | CH |
| DXCM | DEXCOM INC | 2.53% | Equity (US) | US |
| INCY | INCYTE CORP | 2.44% | Equity (US) | US |
| ILMN | ILLUMINA INC | 2.19% | Equity (US) | US |
| ARGX | ARGENX SE ADR | 2.12% | Equity (Foreign) | BE |
| NOVN | NOVARTIS AG | 2.07% | Equity (Foreign) | CH |
| HALO | HALOZYME THERAPEUTICS | 2.04% | Equity (US) | US |
| CYTK | CYTOKINETICS | 1.55% | Equity (US) | US |
| PFE | PFIZER | 1.54% | Equity (US) | US |
| BMY | BRISTOL MYERS SQUIBB | 1.51% | Equity (US) | US |
| NBIX | NEUROCRINE BIOSCIENCES | 1.46% | Equity (US) | US |
| ABT | ABBOTT LABORATORIES | 1.38% | Equity (US) | US |
| GH | GUARDANT HEALTH | 1.36% | Equity (US) | US |
| — | WUXI BIOLOGICS CAYMAN | 1.36% | Equity (Foreign) | CN |
| GALD | GALDERMA GROUP N AG | 1.31% | Equity (Foreign) | CH |
| ROIV | ROIVANT SCIENCES LTD | 1.29% | Equity (US) | US |
| TEM | TEMPUS AI CLASS A | 1.24% | Equity (US) | US |
| RVMD | REVOLUTION MEDICINES | 1.23% | Equity (US) | US |
| BMRN | BIOMARIN PHARMACEUTICAL | 1.22% | Equity (US) | US |
| AXSM | AXSOME THERAPEUTICS | 1.09% | Equity (US) | US |
| XTSLA | BLK CSH FND TREASURY SL AGENCY | 1.02% | Cash/Money Market | US |
| PTGX | PROTAGONIST THERAPEUTICS | 0.94% | Equity (US) | US |
| BRKR | BRUKER | 0.88% | Equity (US) | US |
| USD | USD CASH | 0.70% | Cash/Money Market | US |
| UCB | UCB SA | 0.69% | Equity (Foreign) | BE |
| ALKS | ALKERMES | 0.65% | Equity (US) | US |
| RCUS | ARCUS BIOSCIENCES | 0.62% | Equity (US) | US |
| DNTH | DIANTHUS THERAPEUTICS INC | 0.57% | Equity (US) | US |
| MBX | MBX BIOSCIENCES | 0.49% | Equity (US) | US |
| COGT | COGENT BIOSCIENCES | 0.46% | Equity (US) | US |
| ERAS | ERASCA | 0.31% | Equity (US) | US |
| SGMT | SAGIMET BIOSCIENCES SERIES A | 0.15% | Equity (US) | US |
| AVTX | AVALO THERAPEUTICS | 0.12% | Equity (US) | US |
| EIKN | EIKON THERAPEUTICS INC | 0.11% | Equity (US) | US |
| SMMT | SUMMIT THERAPEUTICS | 0.09% | Equity (US) | US |
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +0.24% | 6 |
| Feb | -1.72% | 6 |
| Mar | -0.70% | 6 |
| Apr | -1.72% | 6 |
| May | -0.38% | 6 |
| Jun | +3.15% | 6 |
| Jul | +1.84% | 6 |
| Aug | +0.91% | 6 |
| Sep | -1.99% | 6 |
| Oct | +0.28% | 5 |
| Nov | +2.71% | 5 |
| Dec | +2.10% | 5 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
- IV Rank (30D)
- 33.44
- IV Rank (7D)
- 100
- Avg IV
- 31.0%
- Straddle (30D)
- $2.33
- Straddle (7D)
- $1.82
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
- Beta (1Y vs SPY)
- 0.57
- Correlation (SPY)
- 42.0%
- R²
- 0.18
- Ann. Volatility
- 17.3%
- SPY Volatility
- 12.8%
Low volatility - stock moves less than market
Click any bar to view the full quote for that stock.
| Symbol | Name | Weight % | Price | 1 Day | 1 Week | 1 Month |
|---|